Two perspectives on lupus: patient and doctor

Abstract

Get full access to this article

View all access options for this article.

References

Lau A. , Feng PH Living with the wolf. APLAR J Rheumatol 2006 ; 6: 317-319.

Seah CS , Wong KH , Chew AGK , Jayaratnam FJ Cyclophosphamide in the treatment of systemic lupus erythematosus . Brit Med J 1966; 1: 333-335.

Feng PH , Jayaratnam FJ , Tock EPC , Seah CS Cyclophosphamide in treatment of systemic lupus erythematosus: 7 years experience . Br Med J 1973; 2: 450-452.

Harman C. Lupus nephritis trials end in disappointment. Nature Rev Nephrol 2009; 5: 303.

Human Genome Sciences. Benlysta (belimumab): A new lupus medication on the horizon. Human Genome Sciences and GSK Announce Positive Phase 3 Study Results for Benlysta. Human Genome Sciences, 20 July 2009.

Bargman JM How did cyclophosphamide become the drug of choice for lupus nephritis . Nephrol Dial Transplant 2009; 24: 381-384.

Baletis JN , Marinaki S. , Skalioti C. , et al. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long term prospective study. Nephrol Dial Transplant 2009; 4: 2157-2160.